34 related articles for article (PubMed ID: 9426739)
1. Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer.
Häggman M
Scand J Urol; 2019 Oct; 53(5):303. PubMed ID: 31701789
[No Abstract] [Full Text] [Related]
2. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D
Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013
[TBL] [Abstract][Full Text] [Related]
3. Focal Ablation of Prostate Cancer.
Lepor H; Gold S; Wysock J
Rev Urol; 2018; 20(4):145-157. PubMed ID: 30787673
[TBL] [Abstract][Full Text] [Related]
4. Focal therapy for localized prostate cancer: is there a "middle ground" between active surveillance and definitive treatment?
Demirel CH; Altok M; Davis JW
Asian J Androl; 2018 Aug; 21(1):37-44. PubMed ID: 30178774
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of conventional US, contrast enhanced US and enhanced MR for the follow-up of prostatic radiofrequency ablation.
Feng C; Hu B; Hu B; Chen L; Li J; Huang J
Exp Ther Med; 2017 Jun; 13(6):3535-3542. PubMed ID: 28588677
[TBL] [Abstract][Full Text] [Related]
6. Focal therapy for prostate cancer: rationale and treatment opportunities.
Kasivisvanathan V; Emberton M; Ahmed HU
Clin Oncol (R Coll Radiol); 2013 Aug; 25(8):461-73. PubMed ID: 23759249
[TBL] [Abstract][Full Text] [Related]
7. Value of MR contrast media in image-guided body interventions.
Saeed M; Wilson M
World J Radiol; 2012 Jan; 4(1):1-12. PubMed ID: 22328966
[TBL] [Abstract][Full Text] [Related]
8. Ablative therapies for renal tumors.
Ramanathan R; Leveillee RJ
Ther Adv Urol; 2010 Apr; 2(2):51-68. PubMed ID: 21789083
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in magnetic resonance imaging of prostate cancer.
Lawrentschuk N; Lindner U
F1000 Med Rep; 2010 Dec; 2():86. PubMed ID: 21283654
[TBL] [Abstract][Full Text] [Related]
10. Image guidance for focal therapy of prostate cancer.
Lindner U; Lawrentschuk N; Trachtenberg J
World J Urol; 2010 Dec; 28(6):727-34. PubMed ID: 20963422
[TBL] [Abstract][Full Text] [Related]
11. Characterization of radiofrequency ablation lesions with gadolinium-enhanced cardiovascular magnetic resonance imaging.
Dickfeld T; Kato R; Zviman M; Lai S; Meininger G; Lardo AC; Roguin A; Blumke D; Berger R; Calkins H; Halperin H
J Am Coll Cardiol; 2006 Jan; 47(2):370-8. PubMed ID: 16412863
[TBL] [Abstract][Full Text] [Related]
12. [Magnetic resonance imaging in the evaluation of temperature-controlled radiofrequency volumetric tissue reduction].
Stuck BA; Köpke J; Maurer JT; Verse T; Eckert A; Düber C; Hörmann K
HNO; 2003 Sep; 51(9):717-20. PubMed ID: 12955249
[TBL] [Abstract][Full Text] [Related]
13. Alternative therapies for localized prostate cancer.
Beerlage HP
Curr Urol Rep; 2003 Jun; 4(3):216-20. PubMed ID: 12756085
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous tumor ablation with radiofrequency.
Wood BJ; Ramkaransingh JR; Fojo T; Walther MM; Libutti SK
Cancer; 2002 Jan; 94(2):443-51. PubMed ID: 11900230
[TBL] [Abstract][Full Text] [Related]
15. Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination.
Djavan B; Zlotta AR; Susani M; Heinz G; Shariat S; Silverman DE; Schulman CC; Marberger M
Urology; 1997 Dec; 50(6):986-92; discussion 992-3. PubMed ID: 9426739
[TBL] [Abstract][Full Text] [Related]
16. Transperineal radiofrequency interstitial tumor ablation (RITA) of the prostate.
Djavan B; Susani M; Shariat S; Zlotta AR; Silverman DE; Schulman CC; Marberger M
Tech Urol; 1998 Jun; 4(2):103-9. PubMed ID: 9623628
[TBL] [Abstract][Full Text] [Related]
17. Transurethral needle ablation (TUNA): histopathological, radiological and clinical studies of a new office procedure for treatment of benign prostatic hyperplasia.
Schulman CC; Zlotta AR
Prog Clin Biol Res; 1994; 386():479-86. PubMed ID: 7528418
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer.
Zlotta AR; Djavan B; Matos C; Noel JC; Peny MO; Silverman DE; Marberger M; Schulman CC
Br J Urol; 1998 Feb; 81(2):265-75. PubMed ID: 9488071
[TBL] [Abstract][Full Text] [Related]
19. Targeted prostate biopsies for a histogram of the index lesion.
Ukimura O; Gill IS
Curr Opin Urol; 2013 Mar; 23(2):118-22. PubMed ID: 23321632
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
